Naropin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
63323-285 -
Package NDC
63323-285-10 -
Package NDC
63323-285-13 -
Package NDC
63323-285-20 -
Package NDC
63323-285-23 -
Package NDC
63323-285-61 -
Package NDC
63323-285-63 -
Package NDC
63323-285-64 -
Package NDC
63323-285-65 -
Application number
NDA020533 -
SPL ID
cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9 -
SPL set ID
23d2d448-a744-4877-9f2d-7e57c198da89 -
UNII
V910P86109 -
RxCUI
905189 -
RxCUI
905191 -
RxCUI
1734084 -
RxCUI
1734086 -
RxCUI
1734090 -
RxCUI
1734091 -
RxCUI
1734203 -
RxCUI
1734204 -
RxCUI
1734207 -
RxCUI
1734208 -
RxCUI
1734347 -
RxCUI
1734348 -
RxCUI
1734355 -
RxCUI
1734356 -
RxCUI
1734475 -
RxCUI
1734476 -
RxCUI
1734479 -
RxCUI
1734480 -
RxCUI
1734481 -
RxCUI
1734482 -
RxCUI
1734483 -
RxCUI
1734484
What the source publishes
- Labeler
- Fresenius Kabi USA, LLC
- Active ingredients
- ROPIVACAINE HYDROCHLORIDE
- Form
- INJECTION, SOLUTION
- Routes
- EPIDURAL, INFILTRATION
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Naropin",
"splId": "cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9",
"labels": [
{
"setId": "23d2d448-a744-4877-9f2d-7e57c198da89",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=23d2d448-a744-4877-9f2d-7e57c198da89",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=23d2d448-a744-4877-9f2d-7e57c198da89"
}
],
"routes": [
"EPIDURAL",
"INFILTRATION"
],
"labeler": "Fresenius Kabi USA, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "5 AMPULE in 1 BOX (63323-285-10) / 10 mL in 1 AMPULE (63323-285-01)",
"package_ndc": "63323-285-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20110531"
},
{
"sample": false,
"description": "25 VIAL, SINGLE-DOSE in 1 CARTON (63323-285-13) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-285-03)",
"package_ndc": "63323-285-13",
"identifierStatus": "well-formed",
"marketing_start_date": "20110531"
},
{
"sample": false,
"description": "5 AMPULE in 1 BOX (63323-285-20) / 20 mL in 1 AMPULE (63323-285-06)",
"package_ndc": "63323-285-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20110531"
},
{
"sample": false,
"description": "25 VIAL, SINGLE-DOSE in 1 CARTON (63323-285-23) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-285-07)",
"package_ndc": "63323-285-23",
"identifierStatus": "well-formed",
"marketing_start_date": "20110531"
},
{
"sample": false,
"description": "24 BAG in 1 CASE (63323-285-61) / 100 mL in 1 BAG (63323-285-02)",
"package_ndc": "63323-285-61",
"identifierStatus": "well-formed",
"marketing_start_date": "20110531"
},
{
"sample": false,
"description": "24 BAG in 1 CASE (63323-285-63) / 200 mL in 1 BAG (63323-285-04)",
"package_ndc": "63323-285-63",
"identifierStatus": "well-formed",
"marketing_start_date": "20110531"
},
{
"sample": false,
"description": "12 BOTTLE in 1 CASE (63323-285-64) / 200 mL in 1 BOTTLE (63323-285-57)",
"package_ndc": "63323-285-64",
"identifierStatus": "well-formed",
"marketing_start_date": "20110531"
},
{
"sample": false,
"description": "12 BOTTLE in 1 CASE (63323-285-65) / 100 mL in 1 BOTTLE (63323-285-51)",
"package_ndc": "63323-285-65",
"identifierStatus": "well-formed",
"marketing_start_date": "20110531"
}
],
"productId": "63323-285_cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "63323-285",
"deaSchedule": null,
"genericName": "ROPIVACAINE HYDROCHLORIDE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ROPIVACAINE HYDROCHLORIDE",
"strength": "2 mg/mL"
}
],
"applicationNumber": "NDA020533",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "19960924",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0363323286033",
"0363323285074",
"0363323285036",
"0363323285579",
"0363323287030",
"0363323286095",
"0363323288075",
"0363323286330",
"0363323286057",
"0363323288037",
"0363323286118",
"0363323285517"
],
"unii": [
"V910P86109"
],
"rxcui": [
"905189",
"905191",
"1734084",
"1734086",
"1734090",
"1734091",
"1734203",
"1734204",
"1734207",
"1734208",
"1734347",
"1734348",
"1734355",
"1734356",
"1734475",
"1734476",
"1734479",
"1734480",
"1734481",
"1734482",
"1734483",
"1734484"
],
"spl_set_id": [
"23d2d448-a744-4877-9f2d-7e57c198da89"
],
"manufacturer_name": [
"Fresenius Kabi USA, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:63323-285_cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9"